And they won't even know it. Just left a meeting were the main topic was do we do business with a potential competitor. The consensus was no and we're talking big bucks in two industries........Bio and the other is secret.
If SQNM finally prevails in the courts re. the IP infringement battle, the price advantage for Verinata's prenatal diag. test will likely be impacted sig.; of course one would assume that ILMN has fully considered this in their DD before acquisition. Lose on that front and SQNM is going to be under renewed short attack.....can see them being taken down hard with a neg. legal outcome, though I wonder if they then become a prime acquisition target for LIFE, DGX, or some BP like Roche or whoever.